According to DelveInsight’s analysis, the mild cognitive impairment market is anticipated to increase during the forecast period (2024–2034), owing to the rise in the launch of emerging therapies and healthcare spending globally. LAS VEGAS, Jan. 8, 2025 /PRNewswire/ — DelveInsight’s Mild…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.